Yuling Zhou
Impact in
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies
-
- Cancer-related molecular mechanisms research
Papers in
-
- Epigenetics and DNA Methylation 3
-
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Craig S. McLachlan (9 shared papers)Brett D. Hambly (7 shared papers)Zhongchao Han (3 shared papers)Dianke Yu (6 shared papers)Chen Wu (5 shared papers)Yan Qiao (7 shared papers)Wen Tan (6 shared papers)Dongxin Lin (5 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Lung Cancer (2 papers)Clinical and Translational Medicine (2 papers)Neuropharmacology (2 papers)Oncogene (1 paper)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Yuling Zhou
46 papers receiving 613 citations
Peers
Comparison fields: 5 of 91
- Otorhinolaryngology 32
- Cancer Research 82
- Physiology 26
- Oncology 103
- Aging 7
Countries citing papers authored by Yuling Zhou
This map shows the geographic impact of Yuling Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuling Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuling Zhou more than expected).
Fields of papers citing papers by Yuling Zhou
This network shows the impact of papers produced by Yuling Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuling Zhou. The network helps show where Yuling Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuling Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 88 | |
| 2 | 2017 | 52 | |
| 3 | 2022 | 51 | |
| 4 | 2013 | 37 | |
| 5 | 2005 | 31 | |
| 6 | 2013 | 27 | |
| 7 | 2016 | 27 | |
| 8 | 2007 | 24 | |
| 9 | 2007 | 24 | |
| 10 | Plasminogen activator inhibitor-1 4G/5G gene polymorphism in patients with myocardial or cerebrovascular infarction in Tianjin, China. | 2003 | 21 |
| 11 | 2018 | 20 | |
| 12 | 2021 | 18 | |
| 13 | 2018 | 17 | |
| 14 | 2022 | 16 | |
| 15 | 2020 | 16 | |
| 16 | 2020 | 16 | |
| 17 | 2020 | 12 | |
| 18 | 2019 | 10 | |
| 19 | 2012 | 10 | |
| 20 | 2015 | 10 |
About Yuling Zhou
Yuling Zhou is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Physiology and Cardiology and Cardiovascular Medicine, having authored 51 papers that have together received 627 indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (4 papers), Lung Cancer Treatments and Mutations (4 papers), Telomeres, Telomerase, and Senescence (3 papers), Epigenetics and DNA Methylation (3 papers), HER2/EGFR in Cancer Research (2 papers), Neurotransmitter Receptor Influence on Behavior (2 papers), Head and Neck Cancer Studies (2 papers) and Adenosine and Purinergic Signaling (2 papers). The work is most often cited by research in Otorhinolaryngology (32 citations), Cancer Research (82 citations), Physiology (26 citations), Oncology (103 citations) and Aging (7 citations). Yuling Zhou has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Craig S. McLachlan, Brett D. Hambly, Zhongchao Han, Dianke Yu, Chen Wu, Yan Qiao, Wen Tan, Dongxin Lin, Jiang Chang and Xuwei Hou. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, Clinical and Translational Medicine, Neuropharmacology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.